Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria / Kulasekararaj, A; Lanza, F; Arvanitakis, A; Langemeijer, SMC; Chonat, S; Chow, V; Pan, J; Saportas, Y; Hanes, V; Henary, H. - In: BLOOD. - ISSN 0006-4971. - ELETTRONICO. - 140:Supplement 1(2022), pp. 8660-8662. [10.1182/blood-2022-166722]
Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria
Lanza, FSecondo
Conceptualization
;
2022
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.